Synergy Cancer Research Results

Synergy, Synergy: Click to Expand ⟱
Source:
Type:

Synergy — Interaction in which two or more agents, treatments, or biological interventions produce a combined effect greater than would be expected from their individual effects. In pharmacology and cancer research, synergy commonly refers to enhanced therapeutic efficacy when a compound is combined with chemotherapy, radiation, targeted therapy, or another bioactive agent.

Typical modulation in cancer: ↑ synergy is generally favorable when it increases tumor-cell killing, suppresses proliferation, enhances apoptosis or ferroptosis, or improves sensitivity to anticancer therapy. Synergy should be distinguished from simple additive effects and ideally supported by quantitative combination analysis such as combination index, Bliss independence, Loewe additivity, or related methods.

Typical modulation in Alzheimer’s disease: Context-dependent. Synergy may describe enhanced neuroprotective, anti-inflammatory, antioxidant, or cognitive effects produced by combinations of compounds or treatments, but it is not a disease-specific molecular pathway.



Scientific Papers found: Click to Expand⟱
8384- LT,    Current situation and research progress of luteolin in the treatment of gastrointestinal malignant tumors
- Review, GC, NA
Apoptosis↑, TumAuto↑, TumCCA↑, EMT↓, *ROS↓, *antiOx↑, ROS↑, P53↑, LC3II↑, Beclin-1/ATG6↑, p‑MAP2K1/MEK1↓, p‑ERK↓, BAX↑, cl‑Casp3↑, Bcl-2↓, p‑MAPK↓, DNArepair↓, HMGB1↓, XRCC1↓, ERCC3↑, CycB/CCNB1↓, CDC2↓, p‑CHK1↑, TumCCA↑, TumCP?, Wnt↓, β-catenin/ZEB1↓, miR-384↑, PTN↓, MMP2↓, MMP3↓, MMP9↓, MMP16↓, Ferroptosis↑, GPx4↓, Synergy↑, Ki-67↓, GSH↓, ChemoSen↑, TumCP↓, TumCMig↓, TumCI↓, PI3K↓, Akt↓, mTOR↓, NF-kB↓, NOTCH↓, miR-139-5p↑, miR-34a↑, miR-422a↑, miR-107↑, miR-21↓, miR-155↓, miR-224↓, miR-340↓, E-cadherin↑, N-cadherin↓, Vim↓, HK1↓, FOXO1↓, compI↓, compIII↓, compV↓, ETC↓, BioAv↝,
8386- LT,    Luteolin induces apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia cell by regulating the PI3K/AKT signaling pathway
- in-vitro, ALL, SUP-B15
tumCV↓, ROS↑, MMP↓, ATP↓, p‑PI3K↓, p‑Akt↓, p‑STAT3↓, Bcl-2↓, BAX↑, cl‑Casp3↑, cl‑Casp9↑, TumCP↓, eff↓, ChemoSen↑, FAK↓, Synergy↑, BioAv↓, BioAv↑,
4292- LT,    Luteolin for neurodegenerative diseases: a review
- Review, AD, NA - Review, Park, NA - Review, MS, NA - Review, Stroke, NA
*Inflam↓, *antiOx↑, *neuroP↑, *BioAv↝, *BBB↑, *TNF-α↓, *IL1β↓, *IL6↓, *IL8↓, *IL33↓, *NF-kB↓, *BACE/β-secretase↓, *ROS↓, *SOD↑, *HO-1↑, *NRF2↑, *Casp3↓, *Casp9↑, *Bax:Bcl2↓, *UPR↑, *GRP78/BiP↑, *Aβ↓, *GSK‐3β↓, *tau↓, *CREB↑, *ATP↑, *cognitive↑, *BloodF↑, *BDNF↑, *TrkB↑, *memory↑, *PPARγ↑, *Synergy↑,
3982- Lut,  Zeax,    Nutritional Intervention to Prevent Alzheimer's Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined
- Trial, AD, NA
*memory↑, *Synergy↑, *Mood↑,
3261- Lyco,    Lycopene and Vascular Health
- Review, Stroke, NA
*Inflam↓, *antiOx↑, *AntiAg↑, *cardioP↑, *SOD↑, *Catalase↑, *ROS↓, *mtDam↓, *cardioP↑, *NF-kB↓, *NO↓, *COX2/PTGS2↓, *LDL↓, *Synergy↑, *ER Stress↓, *BioAv↑, *Synergy↑, *MMPs↓, *COX2/PTGS2↓, *RAGE↓,
3285- Lyco,    Comparative evaluation of antiplatelet effect of lycopene with aspirin and the effect of their combination on platelet aggregation: An in vitro study
- in-vitro, Nor, NA
*AntiAg↑, *Synergy↑,
8414- Lyco,    Exploring the Therapeutic Potential of Lycopene: Mechanisms, Biological Activities, and Health Benefits
- Review, Var, NA - Review, AD, NA
*ROS↓, *Inflam↓, *hepatoP↑, *cardioP↑, *neuroP↑, *AntiArt↑, *Obesity↓, *Wound Healing↑, *BioAv↑, *GSTs↑, *Trx1↑, *SOD↑, *Catalase↑, *ALAT↓, *LDH↓, *AST↓, *MDA↓, *cognitive↑, *memory↑, *NeuroI↓, *Aβ↓, *LRP1↑, *RAGE↓, *NRF2↑, *HO-1↑, tumCV?, Bax:Bcl2↑, DNAdam↑, Apoptosis↑, β-catenin/ZEB1↓, cMyc↓, cycD1/CCND1↓, ROS↓, TumCCA↑, Akt↓, *Synergy↑, *MDA↓, *NF-kB↓, *TGF-β↓, *Casp3↓, *Catalase↑, *GSH↑, *Bcl-2↑, *IL10↑, *MUC1↑, *IBI↑, *RenoP↑, *ChemoSen↑, *Synergy↑, *Synergy↑, *BMD↑,
8413- Lyco,  VitE,    Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation
- in-vivo, AD, NA
*memory↑, *MDA↓, *GPx↑, *tau↓, *Synergy↑,
8415- Lyco,  CUR,    Combination of Lycopene and Curcumin Synergistically Alleviates Testosterone-Propionate-Induced Benign Prostatic Hyperplasia in Sprague Dawley Rats via Modulating Inflammation and Proliferation
- in-vivo, BPH, NA
*Dose↝, *Synergy↑, *Ki-67↓, *testos↓, *DHT↓, *PSA↓, *IL1β↓, *IL6↓, *AKT1↓, *TNF-α↓, *EGFR↓, *STAT3↓, *COX2/PTGS2↓,
4791- Lyco,    Investigating into anti-cancer potential of lycopene: Molecular targets
- Review, Var, NA
*antiOx↑, TumCP↓, TumCCA↓, Apoptosis↑, TumCI↓, angioG↓, TumMeta↓, *Risk↓, cycD1/CCND1↓, CycD3↓, cycE/CCNE↓, CDK2↓, CDK4↓, Bcl-2↓, P21↑, p27/CDKN1B↑, P53↑, BAX↑, selectivity↑, MMP↓, Cyt‑c↑, Wnt↓, Synergy↑, PPARγ↑, LDL↓, Akt↓, PI3K↓, mTOR↓, PDGF↓, NF-kB↓, ChemoSen↑,
4798- Lyco,    Enhancing Anticancer Treatment Efficacy With Lycopene: A Comprehensive Review of Clinical and Preclinical Evidence
- Review, Var, NA
AntiCan↑, ChemoSen↑, eff↑, Synergy↑,
4792- Lyco,    A Comprehensive Review on the Molecular Mechanism of Lycopene in Cancer Therapy
- Review, Var, NA
*AntiCan↑, *antiOx↑, Inflam↓, Wnt↓, β-catenin/ZEB1↓, *ROS↓, BioAv↑, ROS↓, Risk↓, PGE2↓, COX2/PTGS2↓, p‑ERK↓, P21↑, MMP7↓, MMP9↓, ChemoSen↑, Synergy↑,
1708- Lyco,    The Anti-Cancer Activity of Lycopene: A Systematic Review of Human and Animal Studies
- Review, Var, NA
OS↑, ChemoSen↑, QoL↑, PSA∅, Synergy↑, AntiCan↑, AntiCan↑, angioG↓, VEGF↓, Hif1a↓, SOD↑, Catalase↑, GPx↑, GSH↑, GPx↑, GR↑, MDA↓, NRF2↑, HO-1↑, COX2/PTGS2↓, PGE2↓, NF-kB↓, IL4↑, IL10↑, IL6↓, TNF-α↓, PPARγ↑, TumCCA↑, FOXO3↓, Casp3↑, IGF-1↓, p27/CDKN1B↑, STAT3↓, CDK2↓, CDK4↓, P21↑, PCNA↓, MMP7↓, MMP9↓,
1715- Lyco,    Pro-oxidant Actions of Carotenoids in Triggering Apoptosis of Cancer Cells: A Review of Emerging Evidence
- Review, Var, NA
antiOx↑, ROS↑, ChemoSen↑, selectivity↑, eff↓, Casp3↑, Casp7↑, Casp9↑, P53↑, BAX↑, DNAdam↑, mtDam↑, Synergy↑,
8734- M-Blu,    From Mitochondrial Function to Neuroprotection – An Emerging Role for Methylene Blue
- Review, AD, NA
*ETC↑, *compIV↑, *ROS↓, *NeuroI↓, *neuroP↑, *Stroke↓, *cognitive↑, *BBB↑, *BloodF↑, *NOS2↓, *lipid-P↓, *Inflam↓, *Synergy↑, *OCR↑, *compIV↑, *ATP↑, *Casp↓, *MMP↑, *tau↓,
4528- MAG,    Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
- Review, Nor, NA
*Inflam↑, *cardioP↑, *angioG↓, *antiOx↑, *neuroP↑, *Bacteria↓, AntiTum↑, TumCG↓, TumCMig↓, TumCI↓, Apoptosis↑, E-cadherin↑, NF-kB↓, TumCCA↑, cycD1/CCND1↓, PCNA↓, Ki-67↓, MMP2↓, MMP7↓, MMP9↓, TumCG↓, Casp3↑, NF-kB↓, Akt↓, mTOR↓, LDH↓, Ca+2↑, Synergy↑, *toxicity↓, *BioAv↝, *PGE2↓, *TLR2↓, *TLR4↓, *MAPK↓, *PPARγ↓,
8574- Matr,    Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration
- in-vitro, Lung, A549 - ex-vivo, HCC, SMMC-7721 cell
TumCG↓, Bcl-2↓, BAX↑, TumCMig↓, tumCV∅, VEGF↓, Synergy↑,
8538- Matr,    Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling
- in-vitro, BC, MDA-MB-231 - ex-vivo, BC, MDA-MB-231
TumCP↓, Synergy↑, Apoptosis?, Bax:Bcl2↑, TumCI↓, MMP9↓, MMP2↓, Akt↓, NF-kB↓, VEGFR1↓, BioAv↝,
8527- Matr,    Matrine Promotes Human Myeloid Leukemia Cells Apoptosis Through Warburg Effect Mediated by Hexokinase 2
- in-vitro, AML, K562
TumCP↓, Apoptosis↑, Warburg↓, HK2↓, Synergy↑, Glycolysis↓,
8544- Matr,    Matrine in Liver Diseases: Mechanistic Insights and Therapeutic Potential
- Review, BC, NA
*hepatoP↑, *Inflam↓, *ROS↓, *ER Stress↓, *lipid-P↓, TumCP↓, TumCI↓, TumCMig↓, TumAuto↑, Apoptosis↑, *AST↓, *ALAT↓, *SOD↑, *MDA↓, *TNF-α↓, *IL6↓, *NRF2↑, *HO-1?, *NF-kB↓, *Inflam↓, AFP?, PCNA↓, cMyc↓, Bcl-2↓, BAX↑, EMT↓, MDM2↓, P53↑, PI3K↓, Akt↓, mTOR↓, Beclin-1/ATG6↑, NOTCH↑, ChemoSen↑, eff↑, survivin↓, XIAP↓, Synergy↑,
8545- Matr,    Matrine enhances RLS3-induced ferroptosis at non-toxic doses in acute myeloid leukemia cells with MLL rearrangement
- in-vitro, AML, MV411 - in-vitro, ALL, MOLM-13
Ferroptosis↑, Synergy↑, i-Iron↑, ROS↑, MMP↓, GSH↓, xCT/SLC7A11↓, GPx4↓, P53↑,
8934- MBS,  MeJa,    Increased antioxidant activity and polyphenol metabolites in methyl jasmonate treated mung bean (Vigna radiata) sprouts
- in-vitro, Nor, NA
antiOx?, Ingr↑, Synergy↑, Poly↑, Dose↝, Dose↝,
8929- MBS,    Selenium Biofortification Enhances Functional Bioactive Components and Nutritional Quality of Edible Mung Bean Sprouts During Germination
- in-vitro, AD, NA
*GABA↑, *eff↑, *Synergy↑, *eff↑, *Ingr↝, *eff?, *selm↑,
8629- MBZ,    Repurposing the antihelmintic mebendazole as a hedgehog inhibitor
- in-vitro, Nor, NIH-3T3 - vitro+vivo, GBM, GL-15 - in-vitro, GC, DAOY
HH↓, TumCG↓, Synergy↑, Dose↝, Gli1↓, PTCH1↓, α-tubulin↓, Smo↓, toxicity↓, Half-Life↝, toxicity↝,
8631- MBZ,  BEV,    Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer
- Trial, CRC, NA
Dose?, Synergy↑, PFS↑, VEGF↓, ChemoSen↑,
8636- MBZ,    Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer
- in-vivo, Ovarian, SKOV3
TumCG?, P53↑, P21↑, Synergy↑, Dose↝,
8640- MBZ,  GB,    Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines
- in-vitro, Lung, A549 - in-vitro, BC, MDA-MB-231
Synergy↑, tumCV↓, EGFR↓, RCC1↓, MMP2↓, STAT4↓, IL6↓, IL1β↓, TNF-α↑, IFN-γ↓,
8641- MBZ,  ONC201,    The therapeutic potential of repurposed mebendazole, alone and in synergistic combination with ONC201, in the treatment of diffuse midline glioma
- in-vitro, GBM, NA
TumCCA↑, P21↑, p27/CDKN1B↑, Apoptosis↑, Casp3↑, cl‑PARP↑, Synergy↑, ChemoSen↑,
8654- MBZ,  SUL,    Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model
- in-vivo, Colon, HT-29 - in-vitro, Colon, SW48
Synergy↑, COX2/PTGS2↓, angioG↓, VEGFR2/KDR/Flk1↓, Ki-67↓, chemoPv↑,
8650- MBZ,    Autophagy Is a Potential Target for Enhancing the Anti-Angiogenic Effect of Mebendazole in Endothelial Cells
- in-vitro, Var, NA
TumCP↓, TumCCA↑, Apoptosis↑, DNAdam↑, P53↑, Casp3↑, TumAuto↑, Synergy↑, eff↑,
8648- MBZ,    Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
- Review, Var, NA
angioG↓, MMPs↓, MDR1↓, TubPol↓, RadioS?, ChemoSen?, TumCG↓, TumMeta?, OS↑, BioAv↓, BioAv↑, BBB↑, mitA↑, HH↓, Shh↓, Synergy↑, Gli1↓, PTCH2↓, XIAP↓, cl‑PARP↑, Casp3↑, BRAF↓, MEK↓, SYN1↑, Cyt‑c↑, TumVol↓, VEGFR2/KDR/Flk1↓, VEGF↓, VCAM-1↓, DYRK1B↓, QoL↑, Dose↝,
8644- MBZ,    The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer
- vitro+vivo, CRC, HT-29 - in-vitro, CRC, HCT116 - in-vitro, CRC, LoVo - in-vitro, CRC, SW-620
Synergy↑, tumCV↓, PI3K?, Akt?,
8786- mCHEMO,    Metronomic chemotherapy in cancer treatment: new wine in an old bottle
- Review, Var, NA
eff↑, ChemoSideEff↓, angioG↓, *toxicity↓, PFS↑, Hif1a↓, TumCD↑, CSCs↓, EMT↓, Bcl-2↓, BAX↑, Casp3↑, Casp7↑, CD133↓, TumCCA↑, P21↓, DNAdam↑, Imm↑, Synergy↑, Synergy↑,
8787- mCHEMO,    Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy
- Review, Var, NA
*toxicity↓, angioG↓, Imm↑, DCells↑, T-Cell↑, CSCs?, chemoR↓, QoL↑, RadioS↑, Synergy↑,
8788- mCHEMO,    Metronomic Chemotherapy: A Novel Approach in Cancer Treatment
- Review, Var, NA
angioG↓, Imm↑, toxicity↓, TSP-1↑, Synergy↑,
8789- mCHEMO,    Predictive Biomarkers of Metronomic Chemotherapy Response in Solid Tumors: Chasing an Elusive Signal
- Review, Var, NA
Synergy↑, angioG↓, Apoptosis↑, TSP-1↑, Imm↑, NA↑,
8817- MCP,  CPT-11,    Newly Obtained Apple Pectin as an Adjunct to Irinotecan Therapy of Colorectal Cancer Reducing E. coli Adherence and β-Glucuronidase Activity
- in-vitro, CRC, HCT116 - in-vitro, Colon, Caco-2
Synergy↑, tumCV↓, Apoptosis↑, ROS↑, Inflam↓, Bacteria↓, ChemoSideEff↓,
8620- MCT,    Medium-Chain Triglycerides: Scientific and Regulatory Perspectives from Germany and Japan with a US Context—A Concise Review
- Review, Nor, NA
*BioAv↑, *toxicity↓, *Obesity↓, *Akt↑, *mTOR↑, *Synergy↑, *cognitive↑, *Obesity↓,
8725- MeJa,    Methyl jasmonate leads to necrosis and apoptosis in hepatocellular carcinoma cells via inhibition of glycolysis and represses tumor growth in mice
- vitro+vivo, HCC, HCCLM3 - in-vitro, Liver, Bel-7402 - in-vitro, Liver, Hep3B - in-vitro, HCC, SMMC-7721 cell
HK2↓, MMP↓, Cyt‑c↑, AIF↑, Glycolysis↓, ChemoSen↑, selectivity↑, lactateProd↓, GlucoseCon↓, Synergy↑, Synergy↑,
8757- MeSA,    Methylseleninic acid (MSA) inhibits 17β-estradiol-induced cell growth in breast cancer T47D cells via enhancement of the antioxidative thioredoxin/ thioredoxin reductase system
- in-vitro, BC, T47D
ER-α36↓, TumCCA↑, Synergy↑, Trx↑, TrxR↑, ROS↓, other↝,
8754- MeSA,    Thioredoxin reductase 1 ablation sensitizes colon cancer cells to methylseleninate-mediated cytotoxicity
- in-vitro, CRC, RKO
Synergy↑, ER Stress↑, UPR↑,
8764- MeSA,    Methylseleninic acid promotes antitumour effects via nuclear FOXO3a translocation through Akt inhibition
- in-vitro, Lung, A549
FOXO3↑, DNAdam↑, ROS↓, TumCCA↑, Apoptosis↑, ChemoSen↑, Glycolysis↓, TCA↓, Synergy↑,
8707- MET,    Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study
- Review, Var, NA - Review, AD, NA
*BioAv↝, *cardioP↑, *Obesity↓, *neuroP↑, *toxicity↝, *Dose↝, *GutMicro↑, *AMPK↑, *glucose↓, *NLRP3↑, *Inflam↓, *Stroke↓, *Cartilage↑, FOXP3↑, TumAuto↑, mTOR↓, PD-L1↓, RadioS↑, ChemoSen↑, ROS↓, OXPHOS↓, compI↓, Glycolysis↝, TumCP↓, *BioAv↝, *AntiAge↑, *SIRT1↑, *cognitive↑, *Risk↓, Ki-67↓, Synergy↝, PFS∅, OS∅,
8562- MET,    Hexokinase 2 Depletion Confers Sensitization to Metformin and Inhibits Glycolysis in Lung Squamous Cell Carcinoma
- in-vitro, Lung, NA
Synergy↑,
2379- MET,    Down‐regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer
- in-vitro, Bladder, T24/HTB-9 - in-vitro, BC, UMUC3
PKM2↓, p‑STAT3↓, TumCG↓, Synergy↑, chemoP↑, AMPK↑,
2387- MET,  GEM,    Metformin Increases the Response of Cholangiocarcinoma Cells to Gemcitabine by Suppressing Pyruvate Kinase M2 to Activate Mitochondrial Apoptosis
- in-vitro, CCA, HCC9810
Synergy↑, tumCV↓, TumCMig↓, TumCI↓, Apoptosis↑, PKM2↓, PDHB↓,
1043- MET,  immuno,    Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
- in-vitro, Var, NA
Synergy↑, PD-L1↓, Ki-67↑, TIM-3↑, L-sel↑,
5800- MET,    Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect
- Review, Var, NA
ChemoSen↑, RadioS↑, Imm↑, *AntiDiabetic↑, *AMPK↑, TumCP↓, hepatoP↑, ATP↓, AMP↑, glucoNG↓, ROS↑, compI↓, DNAdam↑, CSCs↓, NP/CIPN↓, chemoP↑, toxicity↓, Trx↓, Synergy↑, cycD1/CCND1↓, CDK4↓, CDK6↓, cycE/CCNE↓, CDK2↓,
6936- MF,  Ex,    Pulsed electromagnetic field with or without exercise therapy in the treatment of benign prostatic hyperplasia
- Trial, BPH, NA
*eff↑, *Synergy↑, *BloodF↑, *Diff↝, *Dose↝, *Dose↝, *Dose↝, *Dose↝, *Dose↝, *Dose↝, *Dose↝, *UFR↑, *UR↓, *PSA↓, *other↑, *Inflam↓,
523- MF,  MTX,    Extremely low-frequency magnetic fields significantly enhance the cytotoxicity of methotrexate and can reduce migration of cancer cell lines via transiently induced plasma membrane damage
- in-vitro, AML, THP1 - in-vitro, NA, PC12 - in-vivo, Cerv, HeLa
H2O2↑, TumCD↑, CellMemb↑, Synergy↑,

Showing Research Papers: 301 to 350 of 499
Prev Page 7 of 10 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 499

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 4,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 1,   antiOx↑, 8,   antiOx⇅, 1,   ARE↑, 1,   Catalase↓, 4,   Catalase↑, 3,   Fenton↑, 5,   frataxin↑, 1,   GPx↓, 3,   GPx↑, 3,   GPx4↓, 5,   GPx4↑, 1,   GSH↓, 23,   GSH↑, 1,   GSH↝, 1,   GSR↑, 1,   GSSG↑, 1,   GSTs↓, 1,   H2O2↑, 6,   HO-1↓, 3,   HO-1↑, 11,   hyperG↓, 1,   Iron↑, 5,   i-Iron↑, 2,   Keap1↑, 1,   lipid-P?, 1,   lipid-P↓, 3,   lipid-P↑, 11,   MDA↓, 2,   MDA↑, 5,   NQO1↑, 3,   NRF2↓, 11,   NRF2↑, 15,   PrxI↓, 1,   PYCR1↓, 1,   RNS↑, 1,   ROS?, 2,   ROS↓, 24,   ROS↑, 197,   ROS⇅, 4,   i-ROS↑, 2,   mt-ROS↑, 3,   SOD↓, 6,   SOD↑, 3,   TAC↓, 1,   Trx↓, 3,   Trx↑, 2,   Trx1↓, 1,   Trx2↓, 1,   TrxR↓, 4,   TrxR↑, 2,   TrxR1?, 1,   TrxR1↓, 1,   xCT/SLC7A11↓, 5,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 2,   IronCh↑, 1,   Mets↑, 1,   Tf↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   BCR-ABL↓, 1,   CDC2↓, 3,   CDC25↓, 2,   compI↓, 4,   compIII↓, 4,   compV↓, 1,   EGF↓, 2,   ETC↓, 2,   ETC↑, 1,   ETC↝, 1,   Insulin↓, 2,   MFN2↑, 1,   mitResp↓, 2,   mitResp↑, 3,   Mortalin↓, 1,   mtDam↑, 14,   OCR↓, 3,   OCR↑, 3,   OXPHOS↓, 9,   OXPHOS↑, 7,   OXPHOS↝, 2,   PDH↓, 1,   PDH↑, 5,   p‑PDH↑, 1,   PGC-1α↑, 1,   PINK1↑, 1,   SDH↓, 1,   SIRT3↓, 1,   SIRT3↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 5,   ACC↑, 3,   ACLY↓, 4,   p‑ACLY↓, 1,   ACSL4↑, 2,   adiP↑, 1,   Alanine↓, 1,   ALAT↓, 4,   ALAT↑, 1,   AMP↑, 1,   AMPK↑, 18,   ATP↓, 14,   ATP↑, 2,   mt-ATP↓, 1,   CAIX/CA9↓, 1,   CAIX/CA9↑, 1,   citrate↓, 2,   CPT1A↓, 1,   ECAR↓, 1,   FASN↓, 4,   FASN↑, 1,   GAPDH↓, 1,   glucoNG↓, 1,   glucose↓, 1,   glucose↝, 1,   GlucoseCon↓, 7,   GlucoseCon↑, 1,   GlutMet↓, 1,   glyC↓, 1,   Glycine↓, 1,   Glycolysis↓, 41,   Glycolysis↑, 1,   Glycolysis↝, 1,   GSK‐3β↓, 4,   GSK‐3β↑, 3,   p‑GSK‐3β↓, 2,   p‑GSK‐3β↑, 1,   Histones↝, 1,   HK1↓, 1,   HK2↓, 18,   HMG-CoA↓, 9,   KeyT↑, 1,   lactateProd↓, 12,   lactateProd↑, 1,   LDHA↓, 7,   LDL↓, 3,   lipoGen↓, 2,   MCT4↓, 1,   NAD↓, 1,   NADH:NAD↓, 1,   NADPH↓, 4,   NADPH↑, 2,   PDHB↓, 1,   PDK1 / PDPK1↓, 9,   PDK3↑, 1,   PDKs↓, 10,   PFK↓, 2,   PFK1↓, 1,   PFK2?, 1,   PKM2↓, 12,   PKM2↑, 1,   PLA2↓, 1,   Pyruv↓, 1,   SCD1↓, 1,   SIRT1↓, 3,   SIRT1↑, 4,   SIRT2↓, 2,   SREBP2↓, 2,   TCA↓, 3,   TCA↑, 2,   TS↓, 1,   Warburg↓, 13,   β-oxidation↓, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 3,   APAF1↑, 2,   Apoptosis?, 2,   Apoptosis↓, 4,   Apoptosis↑, 142,   ASK1↑, 1,   BAD↑, 4,   BAD↝, 1,   Bak↑, 5,   BAX↓, 3,   BAX↑, 68,   BAX↝, 2,   Bax:Bcl2↑, 20,   Bcl-2↓, 75,   Bcl-2↑, 2,   Bcl-2↝, 1,   Bcl-xL↓, 17,   Bcl-xL↑, 1,   BID↑, 1,   BIM↑, 7,   BNIP3↑, 1,   Casp↑, 23,   Casp1↑, 1,   Casp12?, 1,   Casp12↑, 1,   Casp2↑, 1,   Casp3↓, 3,   Casp3↑, 83,   cl‑Casp3↑, 14,   cl‑Casp3⇅, 1,   proCasp3↑, 2,   pro‑Casp3↑, 1,   Casp7↑, 7,   cl‑Casp7↑, 3,   Casp8↓, 1,   Casp8↑, 8,   cl‑Casp8↑, 2,   proCasp8↑, 2,   pro‑Casp8↑, 1,   Casp9↓, 1,   Casp9↑, 45,   cl‑Casp9↑, 6,   proCasp9↑, 2,   CellShr↑, 2,   cFLIP↓, 2,   Cupro↑, 1,   Cyt‑c↑, 45,   Diablo↑, 4,   DR5↑, 14,   FADD↑, 3,   Fas?, 1,   Fas↑, 10,   FasL↑, 2,   Ferroptosis↓, 1,   Ferroptosis↑, 15,   GSDME-N↑, 1,   HEY1↓, 1,   IAP1↓, 4,   IAP2/BIRC3↓, 1,   cl‑IAP2/BIRC3↑, 1,   ICD↑, 2,   iNOS↓, 7,   iNOS↑, 2,   Mcl-1↓, 17,   Mcl-1↑, 1,   MDM2↓, 3,   MDM2↑, 1,   MLKL↑, 1,   p‑MLKL↓, 1,   MOMP↑, 3,   Necroptosis↑, 3,   necrosis↑, 2,   NOXA↑, 1,   p38↓, 3,   p38↑, 6,   p‑p38↓, 1,   p‑p38↑, 2,   Paraptosis↑, 2,   PUMA↑, 3,   Pyro↑, 4,   RIP3↑, 1,   p‑RIP3↑, 1,   survivin↓, 27,   TNFR 1↑, 1,   TRAIL↑, 1,   TumCD↓, 2,   TumCD↑, 22,   XIAP↓, 15,   YAP/TEAD↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 1,   Akt↓, 77,   Akt↑, 11,   p‑Akt↓, 19,   Akt2↓, 1,   AMPKα↑, 1,   BRAF↓, 1,   CK2↓, 4,   cSrc↓, 1,   DYRK1B↓, 1,   EF-1α↓, 1,   EGFR↓, 23,   ERK↓, 15,   ERK↑, 6,   ERK↝, 1,   p‑ERK↓, 11,   FGFR1↓, 1,   FOXD3↑, 1,   HCAR2↑, 1,   HER2/EBBR2↓, 9,   HGF/c-Met↓, 1,   IGF-1R↓, 4,   IGF-1R↑, 1,   IKKα↓, 3,   IκB↓, 1,   IκB↑, 1,   JAK↓, 3,   JAK1↓, 2,   JAK2↓, 8,   JAK3↓, 1,   JNK↓, 3,   JNK↑, 11,   p‑JNK↓, 3,   p‑JNK↑, 1,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 11,   MAPK↑, 7,   MAPK↝, 1,   p‑MAPK↓, 1,   MEK↓, 6,   mTOR↓, 49,   mTOR↑, 2,   mTOR↝, 1,   p‑mTOR↓, 4,   mTORC2↓, 1,   p70S6↓, 1,   P70S6K↓, 3,   p‑P70S6K↓, 3,   P90RSK↓, 1,   PDGFR-BB↓, 2,   p‑PDGFR-BB↓, 1,   PFKFB2↓, 1,   PI3K?, 1,   PI3K↓, 58,   PI3K↑, 4,   p‑PI3K↓, 3,   PI3K/Akt↓, 1,   PKA↓, 1,   PKA↑, 1,   PKCδ↓, 5,   PP2A↑, 1,   PTEN↑, 12,   Raf↓, 2,   c-Raf↓, 1,   RAS↓, 6,   RCC1↓, 1,   p‑S6K↓, 1,   SHP1↑, 2,   Sp1/3/4↓, 7,   Src↓, 1,   STAT↓, 2,   STAT3↓, 46,   STAT3↝, 1,   p‑STAT3↓, 9,   p‑STAT3↑, 4,   STAT4↓, 2,   STAT5↓, 2,   STAT6↓, 2,   STK11/LKB1↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF3↑, 1,   ATF4↓, 1,   ATF4↑, 7,   ChrMod↝, 1,   cJun↓, 7,   cJun↑, 3,   cMyc↓, 24,   DNMT1↓, 7,   DNMT3A↓, 2,   DNMT3B↓, 1,   DNMTs↓, 7,   EZH2↓, 3,   FOXM1↓, 3,   FOXO↑, 1,   FOXO1↓, 3,   FOXO3↓, 2,   FOXO3↑, 8,   FOXO4↓, 1,   FOXO4↑, 1,   H3↑, 2,   ac‑H3↑, 3,   H3K4↓, 1,   H3K9↓, 3,   H4↑, 1,   ac‑H4↑, 3,   HATs↓, 3,   HATs↑, 1,   HDAC↓, 21,   HDAC1↓, 3,   HDAC2↓, 4,   HDAC3↓, 3,   HDAC6↓, 1,   HDAC8↓, 2,   HMTs↓, 1,   KLF2↓, 1,   KLF4↓, 1,   KLF5↓, 1,   miR-107↑, 1,   miR-124-3p↓, 1,   miR-126↑, 1,   miR-139-5p↑, 1,   miR-155↓, 1,   miR-200b↑, 1,   miR-200c↑, 1,   miR-21↓, 2,   miR-224↓, 1,   miR-25-5p↓, 1,   miR-27a-3p↓, 1,   miR-29b↓, 1,   miR-340↓, 1,   miR-34a↓, 1,   miR-34a↑, 2,   miR-375↑, 1,   miR-384↑, 1,   miR-422a↑, 1,   Myc↓, 4,   Myc↑, 1,   MYCN↑, 1,   n-MYC↓, 2,   NDRG1↑, 1,   OCT4↓, 9,   OLIG2↓, 1,   other↓, 5,   other↑, 9,   other⇅, 1,   other↝, 12,   PCAF↓, 1,   PhotoS↑, 3,   sonoS↑, 2,   SOX2↓, 5,   SOX4↓, 2,   SOX9?, 1,   SOX9↓, 1,   SUV39H↓, 3,   TCF-4↓, 1,   tumCV?, 1,   tumCV↓, 40,   tumCV↑, 2,   tumCV∅, 1,   ZBTB10↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 10,   cl‑CHOP/DDIT3↑, 1,   eIF2α↑, 3,   p‑eIF2α↑, 2,   ER Stress↑, 38,   GRP78/BiP↓, 2,   GRP78/BiP↑, 9,   GRP78/BiP↝, 1,   GRP94↑, 1,   HSP27↓, 4,   HSP70/HSPA5↓, 7,   HSP70/HSPA5↑, 4,   HSP72↑, 1,   HSP90↓, 9,   HSPs↓, 1,   HSPs↑, 1,   IRE1↑, 3,   p‑IRE1↑, 1,   PERK↑, 5,   Proteasome?, 1,   Proteasome↓, 3,   UPR↑, 10,   XBP-1↓, 1,   XBP-1↝, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↑, 1,   ATG5↑, 2,   ATG7↑, 2,   autoF↓, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 9,   p‑Beclin-1/ATG6↑, 1,   CTSB↓, 1,   CTSD↓, 1,   CTSL↑, 1,   LAMP2↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3B↑, 2,   LC3II↓, 1,   LC3II↑, 10,   LC3s↓, 1,   lysosome↓, 1,   MitoP↑, 1,   p62↓, 5,   p62↑, 6,   PARK2↑, 1,   SESN2↑, 1,   TumAuto↓, 1,   TumAuto↑, 39,   TumAuto⇅, 2,  

DNA Damage & Repair(tgid=10) ⓘ

APE1/APEX1↓, 1,   BRCA1↓, 1,   DNA-PK↑, 2,   DNAdam↑, 46,   DNArepair↓, 3,   DNArepair↑, 1,   ERCC1↓, 1,   ERCC3↑, 1,   m-FAM72A↓, 1,   hTERT/TERT↓, 10,   MGMT↓, 1,   NKX3.1↓, 1,   p16↑, 1,   P53↓, 2,   P53↑, 43,   p‑P53↓, 1,   p‑P53↑, 3,   PARP↑, 10,   p‑PARP↑, 1,   cl‑PARP↓, 1,   cl‑PARP↑, 39,   cl‑PARP↝, 1,   PARP1↑, 1,   cl‑PARP1↑, 3,   PCNA↓, 14,   POLD1↓, 1,   SIRT6↓, 1,   Telomerase↓, 7,   TOP1↓, 5,   TOP2↓, 2,   TOP2↑, 1,   TP53↓, 2,   TP53↑, 3,   XRCC1↓, 1,   γH2AX↑, 5,  

Cell Cycle & Senescence(tgid=11) ⓘ

AURKB↓, 1,   CC(CDKs/cyclins)↓, 2,   CDK1↓, 10,   CDK2↓, 23,   CDK4↓, 30,   CDK4↑, 3,   CDK6↓, 9,   CDK6↑, 4,   CDKN1C/p57↑, 1,   CHK1↓, 2,   p‑CHK1↑, 1,   Chk2↓, 1,   ChrCon↑, 1,   Cyc↓, 2,   cycA1/CCNA1↓, 5,   CycB/CCNB1↓, 13,   cycD1/CCND1↓, 45,   CycD3↓, 3,   cycE/CCNE↓, 16,   cycE1↓, 1,   E2Fs↓, 2,   GADD45A↑, 1,   Ki-67↓, 26,   Ki-67↑, 1,   mitA↑, 2,   P21?, 2,   P21↓, 4,   P21↑, 28,   p27/CDKN1B↓, 2,   p27/CDKN1B↑, 10,   pRB↓, 1,   p‑pRB↓, 2,   RB1↑, 1,   p‑RB1↓, 3,   RRM2↓, 1,   Securin↓, 1,   TubPol↓, 1,   TumCCA?, 1,   TumCCA↓, 4,   TumCCA↑, 111,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 5,   ALDH1A1↓, 1,   CD133↓, 4,   CD133↑, 1,   CD24↓, 1,   cFos↓, 7,   cMYB↓, 2,   CSCs?, 1,   CSCs↓, 41,   CSCsMark↓, 1,   Diff↓, 3,   Diff↑, 6,   FGF↓, 1,   Gli↓, 1,   Gli1↓, 6,   HH↓, 8,   HMGCR↓, 1,   HMGCR↑, 1,   HMGCR⇅, 1,   IGF-1?, 1,   IGF-1↓, 7,   IGFBP1↑, 2,   IGFBP3↑, 1,   Ki-67↓, 26,   Ki-67↑, 1,   Let-7↑, 2,   LRP6↓, 1,   mTORC1↓, 5,   p‑mTORC1↓, 1,   Nanog↓, 11,   Nestin↓, 3,   NOTCH↓, 6,   NOTCH↑, 2,   NOTCH1↓, 8,   NOTCH1↑, 4,   NOTCH2↑, 1,   NOTCH3↓, 3,   OGFr↑, 1,   p300↓, 1,   PTCH1↓, 3,   PTCH2↓, 2,   SAL↑, 1,   Shh↓, 4,   Smo↓, 2,   TumCG?, 1,   TumCG↓, 83,   TumCG↑, 3,   TumCP?, 1,   TumCP↓, 82,   TumCP↑, 2,   tyrosinase↓, 1,   Wnt↓, 23,   Wnt↑, 2,   Wnt/(β-catenin)↓, 1,  

Migration(tgid=13) ⓘ

annexin II↓, 1,   AntiAg?, 1,   AntiAg↓, 1,   AntiAg↑, 2,   AP-1↓, 7,   AXL↓, 1,   BACH1↓, 1,   Ca+2↓, 2,   Ca+2↑, 16,   CAFs/TAFs↓, 1,   cal2↑, 1,   Cal9↑, 1,   CD11b↑, 2,   Cofilin↓, 1,   COL1↓, 2,   E-cadherin↓, 4,   E-cadherin↑, 31,   EMT↓, 54,   EMT↑, 2,   FAK↓, 5,   p‑FAK↓, 2,   fascin↓, 2,   Fibronectin↓, 7,   GLI2↓, 1,   ITGB1↓, 1,   ITGB3↓, 1,   ITGB4↓, 1,   KAI1/CD82↑, 1,   KRAS↓, 2,   L-sel↑, 1,   LAMs↓, 2,   MALAT1↓, 3,   MET↓, 1,   MMP-10↓, 1,   MMP1↓, 4,   MMP13↓, 1,   MMP15↓, 1,   MMP16↓, 1,   MMP2↓, 48,   MMP2↑, 1,   MMP3↓, 2,   MMP7↓, 6,   MMP9↓, 57,   MMP9↑, 2,   MMPs↓, 20,   MUC1↑, 1,   MUC4↓, 1,   N-cadherin↓, 18,   PAK1↓, 1,   PDGF↓, 2,   RECK↑, 1,   Rho↓, 1,   ROCK1↓, 3,   Slug↓, 10,   Smad1↓, 2,   SMAD2↓, 1,   SMAD3↓, 1,   Snail?, 1,   Snail↓, 15,   STAC2↓, 1,   T-cadherin↓, 1,   TET1↑, 4,   TGF-β↓, 12,   TGF-β1↓, 1,   TIMP1↓, 1,   TIMP1↑, 4,   TIMP2↓, 2,   TIMP2↑, 4,   pol-TregCell↓, 1,   TRIB3↑, 1,   TSP-1↑, 4,   TumCA↓, 2,   TumCI↓, 62,   TumCMig↓, 51,   TumCMig↑, 1,   TumMeta?, 1,   TumMeta↓, 44,   TumMeta↑, 3,   Twist↓, 8,   uPA↓, 9,   uPAR↓, 2,   Vim?, 1,   Vim↓, 22,   Zeb1↓, 12,   Zeb1↑, 1,   ZEB2↓, 2,   α-SMA↓, 1,   α-tubulin↓, 1,   β-catenin/ZEB1↓, 30,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 69,   angioG↑, 2,   CD31/PECAM-1↓, 1,   ECM/TCF↓, 1,   eNOS↓, 2,   eNOS↑, 1,   HIF-1↓, 6,   Hif1a↓, 40,   Hif1a↑, 1,   Hypoxia↓, 2,   NO↓, 4,   NO↑, 3,   VCAM-1↓, 3,   VEGF↓, 69,   VEGFR1↓, 3,   VEGFR2/KDR/Flk1↓, 10,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 5,   BBB∅, 1,   CellMemb↑, 1,   CLDN1↓, 3,   CLDN2↓, 1,   CLDN2↑, 1,   CLDN7↑, 1,   EPR↓, 1,   EPR↑, 3,   GLUT1↓, 7,   GLUT1↑, 1,   GLUT2↓, 1,   GLUT3↑, 1,   GLUT4↓, 1,   MMP?, 1,   MMP↓, 62,   MMP↑, 4,   MMP↝, 1,   MPT↑, 4,   SMCT1∅, 1,   TRPM7↓, 1,   TRPV1↓, 1,   TRPV1↑, 1,   TRPV2↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCR7↓, 1,   CD4+↑, 4,   CD44↓, 7,   CD47↓, 1,   CD59↑, 1,   CD8+↑, 10,   COX1↓, 1,   COX2/PTGS2↓, 55,   COX2/PTGS2↑, 3,   CXCL12↓, 2,   CXCR4↓, 10,   DCells↑, 1,   DR4↑, 5,   Eos↑, 1,   FOXP3↓, 1,   FOXP3↑, 1,   HCAR2↑, 1,   HMGB1↓, 3,   ICAM-1↓, 2,   IFN-γ↓, 3,   IFN-γ↑, 3,   IL1↓, 1,   IL10↓, 4,   IL10↑, 1,   IL12↓, 1,   IL12↑, 2,   IL1α↓, 1,   IL1β↓, 14,   IL1β↑, 1,   IL2↓, 3,   IL2↑, 4,   IL4↓, 2,   IL4↑, 2,   IL6↓, 24,   IL8↓, 6,   Imm↑, 26,   Imm↝, 3,   INF-γ↑, 1,   Inflam↓, 22,   pol-M1↑, 1,   M2 MC↓, 3,   MCP1/CCL2↓, 6,   MIP-1β↑, 1,   MIP2↓, 1,   MyD88↑, 1,   NF-kB↓, 73,   NF-kB↑, 4,   NF-kB↝, 1,   p‑NF-kB↓, 1,   NK cell↑, 10,   NLRP3↓, 2,   p65↓, 4,   ac‑p65↓, 1,   PD-1↓, 4,   PD-L1↓, 7,   PD-L1↑, 1,   PGE1↓, 1,   PGE2↓, 21,   PSA↓, 6,   PSA∅, 1,   T-Cell↑, 3,   T-Cell↝, 1,   TCF↓, 1,   TCF↑, 1,   Th1 response↑, 4,   Th17↑, 1,   Th2↑, 1,   TIM-3↑, 1,   TLR4↓, 2,   TLR4↑, 1,   TNF-α↓, 18,   TNF-α↑, 4,   TRADD↑, 1,   Treg lymp↓, 2,  

Cellular Microenvironment(tgid=17) ⓘ

pH↓, 2,   pH↑, 1,   pH↝, 1,   e-pH↑, 4,   i-pH↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 2,   PTN↓, 1,   SYN1↑, 1,  

Protein Aggregation(tgid=19) ⓘ

PSEN1/PS1↓, 1,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ADRB2↓, 1,   AR↓, 12,   COMT↓, 2,   CYP19↓, 1,   ER-α36↓, 4,   ER(estro)↓, 1,   ERα/ESR1↓, 1,   Estro↝, 1,   EstroRS/ERS↑, 1,   FGF21↓, 1,   GR↑, 1,   PPARα↓, 2,   PPARα↑, 1,   PPARγ↓, 1,   PPARγ↑, 4,   RANKL↓, 1,   SXR↓, 1,   SXR↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1,   BioAv↓, 23,   BioAv↑, 37,   BioAv↝, 13,   BioEnh↑, 1,   CBR1↓, 1,   chemoR↓, 2,   ChemoSen?, 3,   ChemoSen↓, 3,   ChemoSen↑, 161,   ChemoSen⇅, 2,   CompStab↝, 1,   CYP1A1↓, 1,   CYP1A1↑, 2,   CYP1A2↓, 2,   CYP1B1↓, 1,   CYP2C9↓, 1,   CYP3A4↓, 3,   DDS↑, 1,   Dose?, 6,   Dose↓, 5,   Dose↑, 10,   Dose↝, 64,   Dose∅, 15,   eff↓, 34,   eff↑, 96,   eff↝, 7,   eff∅, 2,   GSTP1/GSTπ↓, 2,   GSTZ1↓, 1,   Half-Life↓, 8,   Half-Life↑, 4,   Half-Life↝, 7,   Half-Life∅, 1,   MDR1↓, 9,   MRP1/ABCC1↓, 1,   P-gp/ABCB1↓, 11,   P-gp/ABCB1↝, 1,   P-gp/ABCB1∅, 1,   P450↓, 2,   RadioS?, 1,   RadioS↑, 53,   selectivity?, 1,   selectivity↓, 1,   selectivity↑, 80,   selectivity↝, 1,   Synergy?, 2,   Synergy↓, 1,   Synergy↑, 524,   Synergy↝, 1,   Synergy∅, 1,   TET2↑, 2,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   AFP↓, 1,   ALAT↓, 4,   ALAT↑, 1,   ALB∅, 1,   ALP↓, 2,   AR↓, 12,   ascitic↓, 1,   AST↓, 2,   AST↑, 1,   BG↓, 3,   BloodF⇅, 1,   BRAF↓, 1,   BRCA1↓, 1,   CRP↓, 2,   CRP∅, 1,   E6↓, 2,   E7↓, 2,   EGFR↓, 23,   ERα/ESR1↓, 1,   EstroRS/ERS↑, 1,   EZH2↓, 3,   Ferritin↓, 2,   FOXM1↓, 3,   HER2/EBBR2↓, 9,   hTERT/TERT↓, 10,   IL6↓, 24,   IRes↓, 1,   KeyT↑, 1,   KRAS↓, 2,   LDH↓, 11,   p‑LDH↓, 1,   Myc↓, 4,   Myc↑, 1,   NOS2↓, 1,   PD-L1↓, 7,   PD-L1↑, 1,   Polyps↓, 1,   PSA↓, 6,   PSA∅, 1,   RBC↑, 1,   TG/TAG↓, 1,   TP53↓, 2,   TP53↑, 3,   TRIB3↑, 1,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 2,   AntiCan↑, 37,   AntiCan∅, 1,   antiNeop↑, 3,   AntiTum↓, 3,   AntiTum↑, 19,   cachexia↓, 1,   cardioP↑, 5,   CardioT↓, 1,   chemoP?, 1,   chemoP↑, 25,   chemoPv↑, 11,   ChemoSideEff↓, 13,   CR↑, 2,   fatigue↓, 3,   hepatoP↓, 1,   hepatoP↑, 6,   memory↑, 1,   Mucositis↓, 1,   neuroP↑, 5,   NP/CIPN↓, 3,   ORR↑, 1,   OS↑, 34,   OS∅, 1,   Pain↓, 1,   PDE4↓, 1,   PFS↓, 1,   PFS↑, 3,   PFS∅, 1,   Pin1↓, 2,   QoL↑, 9,   QoL∅, 2,   radioP↑, 9,   Remission↑, 3,   RenoP↑, 4,   Risk↓, 25,   Risk↑, 2,   Risk∅, 1,   Sleep↑, 1,   toxicity↓, 25,   toxicity↑, 3,   toxicity↝, 11,   toxicity∅, 5,   TumVol↓, 23,   TumW↓, 11,   Weight∅, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 3,   GutMicro↑, 9,   Sepsis↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↑, 1,   Ingr↝, 7,   Poly↑, 1,  
Total Targets: 977

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 5,   antiOx↑, 78,   ARE↑, 1,   Catalase↑, 31,   Copper↓, 1,   Fenton↓, 1,   GPx↑, 23,   GPx4↑, 2,   GSH↑, 25,   GSR↑, 3,   GSSG↓, 1,   GSSG∅, 1,   GSTs↑, 9,   H2O2↓, 2,   H2O2↑, 1,   H2O2∅, 1,   HDL↑, 3,   HDL∅, 1,   HO-1?, 2,   HO-1↓, 1,   HO-1↑, 22,   Iron↓, 1,   i-Iron↓, 1,   Keap1↓, 3,   Keap1↝, 1,   lipid-P↓, 29,   MDA↓, 22,   MDA↑, 1,   MPO↓, 5,   NQO1↑, 1,   Nrf1↑, 2,   NRF2↑, 44,   Prx↑, 1,   RNS↓, 2,   ROS?, 2,   ROS↓, 84,   ROS↝, 1,   mt-ROS?, 1,   SAM-e↑, 1,   selenoP↑, 1,   SOD↑, 44,   SOD2↑, 2,   TAC↑, 8,   TBARS↓, 2,   Trx↑, 1,   Trx1↑, 1,   uricA↓, 1,   VitC↑, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 5,   selm↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compI↑, 1,   compII↑, 1,   compIII↑, 1,   compIV↑, 2,   DRP1/DNM1L↓, 1,   EGF↓, 1,   ETC↑, 1,   FIS1↓, 2,   Insulin↑, 1,   mtDam↓, 3,   OCR↑, 1,   PGC-1α↑, 2,   PGC-1α↝, 1,   TFAM↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 3,   ACC↓, 1,   adiP↑, 1,   ALAT↓, 10,   AMPK↓, 1,   AMPK↑, 9,   ATP↓, 1,   ATP↑, 9,   ATP↝, 1,   cytoP450↓, 1,   FABP4↓, 1,   FASN↓, 1,   glucose↓, 6,   glucose↝, 1,   GlucoseCon↑, 2,   GSK‐3β↓, 9,   p‑GSK‐3β↑, 1,   H2S↑, 1,   LDL↓, 10,   lipidLev↓, 3,   NAD↓, 1,   NAD↑, 1,   NAD↝, 1,   NADPH↓, 1,   NADPH↑, 1,   PONs↑, 1,   SCFAs↑, 1,   SIRT1↑, 8,   SREBF2⇅, 1,   SREBP1/SREBF1↑, 1,  

Cell Death(tgid=5) ⓘ

AIF↓, 2,   Apoptosis↓, 7,   BAX↓, 4,   BAX↑, 1,   Bax:Bcl2↓, 2,   Bcl-2↓, 2,   Bcl-2↑, 3,   Casp↓, 1,   Casp12↓, 1,   Casp3?, 1,   Casp3↓, 8,   Casp3↑, 1,   cl‑Casp8↑, 1,   Casp9↓, 2,   Casp9↑, 1,   Cyt‑c↓, 3,   Fas↓, 1,   FasL↓, 1,   Ferroptosis↓, 4,   GranB/GZMB↓, 1,   iNOS↓, 12,   p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 5,   Akt↑, 5,   AKT1↓, 1,   Akt2↓, 1,   AMPKα↑, 1,   CREB↑, 2,   p‑CREB↑, 2,   EGFR↓, 1,   ERK↓, 3,   ERK↑, 2,   IKKα↓, 1,   JNK↓, 2,   p‑JNK↓, 1,   MAPK↓, 7,   MAPK↑, 2,   mTOR↓, 3,   mTOR↑, 2,   PI3K↓, 5,   PI3K↑, 2,   PKCδ?, 1,   PKCδ↓, 3,   PKCδ↑, 2,   PTEN↓, 1,   PTEN↑, 1,   RAS↓, 1,   STAT↓, 1,   STAT3↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 3,   ATF4↓, 2,   p‑cMyc↑, 1,   HDAC↓, 1,   HDAC↑, 1,   other↓, 3,   other↑, 14,   other↝, 14,   other?, 1,   other∅, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 2,   p‑eIF2α↓, 1,   ER Stress↓, 5,   GRP78/BiP↓, 2,   GRP78/BiP↑, 1,   UPR↑, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3II↓, 1,   LC3II↑, 1,   MitoP↑, 3,   p62↓, 1,   p62↑, 2,   PARK2↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 5,   P53↓, 1,   PARP1↓, 1,   Telomerase↓, 1,   TOP1↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

GADD34↓, 1,   GADD45A↑, 1,   Ki-67↓, 1,   Ki-67↑, 1,   P21↓, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   BMPs↑, 1,   CEBPA↓, 1,   Choline↑, 1,   Diff↝, 1,   GH↑, 1,   IGF-1↑, 1,   IGFBP1↑, 1,   Ki-67↓, 1,   Ki-67↑, 1,   neuroG↑, 1,   TumCG∅, 1,   Wnt↑, 2,  

Migration(tgid=13) ⓘ

AntiAg↓, 2,   AntiAg↑, 8,   AP-1↓, 3,   Ca+2?, 1,   Ca+2↓, 2,   Ca+2↑, 1,   Ca+2↝, 3,   Cartilage↑, 3,   LRP1↑, 1,   MLC2/MYL9↝, 1,   MMP2↓, 1,   MMP9↓, 1,   MMPs↓, 3,   MUC1↑, 1,   serineP↓, 1,   TGF-β↓, 3,   TGF-β↑, 1,   TGF-β1↓, 1,   uPA↑, 1,   α-SMA↝, 1,   β-catenin/ZEB1↑, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 3,   angioG↑, 2,   eNOS↓, 1,   HIF-1↓, 1,   Hif1a↓, 1,   Hif1a↑, 1,   NO?, 1,   NO↓, 9,   NO↑, 1,   TXA2↓, 1,   VCAM-1↓, 6,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 2,   BBB↑, 15,   BBB↝, 1,   EPR↑, 1,   GastroP↑, 2,   GLUT2↑, 1,   GLUT3↑, 1,   GLUT4↑, 2,   IBI↑, 3,   memfluid↑, 1,   MMP↑, 8,   MUC19↓, 1,   MUC2↓, 1,   OCLN↑, 1,   OCLN↝, 1,   TJ↑, 1,   TRPA1↑, 1,   TRPV3↑, 1,   VGSC↓, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD4+↑, 1,   COX1↓, 2,   COX2/PTGS2↓, 19,   COX2/PTGS2↑, 1,   ICAM-1↓, 3,   IFN-γ↓, 3,   IFN-γ↑, 2,   IL1?, 1,   IL1↓, 3,   IL10↓, 3,   IL10↑, 4,   IL12↓, 1,   IL17↓, 3,   IL18↓, 2,   IL1β↓, 22,   IL2↓, 2,   IL33↓, 1,   IL4↓, 2,   IL4↑, 1,   IL6?, 2,   IL6↓, 35,   IL8↓, 3,   Imm↓, 1,   Imm↑, 8,   Imm↝, 1,   INF-γ↑, 1,   Inflam?, 1,   Inflam↓, 98,   Inflam↑, 2,   IRF3↓, 1,   LPS↓, 1,   pol-M2 MC↑, 1,   MCP1/CCL2↓, 2,   MCP1/CCL2↝, 1,   MyD88↓, 1,   NeuroI↓, 5,   NF-kB↓, 33,   p‑NF-kB↓, 1,   NK cell↑, 1,   NLRP3↓, 8,   NLRP3↑, 1,   PGE2↓, 9,   PSA↓, 2,   RAGE↓, 2,   TLR2↓, 2,   TLR4↓, 3,   TLR4↑, 1,   TNF-α?, 1,   TNF-α↓, 44,   TNF-α↑, 1,   VitD↑, 2,   β-HEX↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 2,   pH↝, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 3,   Ach↑, 2,   AChE↓, 11,   BChE↓, 3,   BDNF↓, 1,   BDNF↑, 12,   ChAT↑, 1,   GABA↑, 3,   MAOA↓, 3,   MAOB↓, 1,   NGF↑, 1,   PSD95↑, 1,   RELN↑, 1,   SNAP25↑, 1,   TrkB↑, 2,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 2,   APP↓, 3,   Aβ↓, 18,   BACE/β-secretase↓, 9,   PSEN1/PS1↓, 2,   PSEN2/PS-2↓, 1,   tau↓, 8,   p‑tau↓, 9,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

CYP19↓, 1,   DHT↓, 1,   Leptin↓, 1,   PPARγ↓, 3,   PPARγ↑, 3,   p‑PPARγ↓, 1,   testos↓, 1,   testos↑, 1,   TSHR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1,   BioAv↓, 26,   BioAv↑, 47,   BioAv⇅, 2,   BioAv↝, 18,   BioEnh↑, 3,   ChemoSen↑, 2,   CompStab↑, 2,   CompStab↝, 2,   CYP3A2↓, 1,   Dose?, 1,   Dose↑, 4,   Dose↝, 31,   eff?, 1,   eff↓, 1,   eff↑, 19,   GSTA1↑, 1,   Half-Life↓, 2,   Half-Life↑, 1,   Half-Life↝, 11,   MRP1/ABCC1↓, 1,   P-gp/ABCB1↓, 1,   P450↓, 2,   selectivity↑, 2,   Synergy↑, 87,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 10,   ALP↓, 2,   AST↓, 14,   BloodF↑, 3,   BMD↑, 3,   BP↓, 9,   BP↝, 2,   Calcium↑, 1,   CK/CK-MB↓, 1,   creat↓, 3,   CRP↓, 8,   EGFR↓, 1,   Hcy/homoC↝, 1,   HOMA↓, 1,   hs-CRP↓, 3,   IL6?, 2,   IL6↓, 35,   LDH↓, 3,   Mag↑, 1,   NOS2↓, 1,   PSA↓, 2,   RAGE↓, 2,   TC↓, 3,   TG/TAG↓, 2,   TMAO↓, 1,   UFR↑, 1,   UR↓, 1,   Urea↓, 2,   VitD↑, 2,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 2,   AntiAge↑, 5,   antiAll↑, 9,   AntiArt↑, 5,   AntiCan↑, 17,   AntiDiabetic↑, 15,   AntiMyl↑, 1,   antiPs↑, 2,   AntiTum↓, 1,   AntiTum↑, 3,   cardioP↓, 1,   cardioP↑, 35,   CardioT↓, 1,   chemoP↑, 11,   chemoPv↑, 5,   ChemoSideEff↓, 1,   cognitive↑, 31,   cognitive↝, 1,   diuretic↑, 2,   hepatoP↑, 29,   Learn↑, 3,   memory↑, 25,   Mood↑, 2,   motorD↑, 3,   neuroP↓, 1,   neuroP↑, 64,   Obesity↓, 12,   Pain↓, 5,   QoL↑, 2,   radioP↑, 8,   RenoP↑, 11,   Risk↓, 5,   Sleep↑, 6,   Strength↑, 1,   Stress↓, 2,   Stroke↓, 6,   toxicity↓, 38,   toxicity↑, 2,   toxicity⇅, 1,   toxicity↝, 11,   toxicity∅, 6,   Weight↓, 1,   Wound Healing↑, 3,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 6,   AntiFungal↓, 1,   AntiFungal↑, 4,   AntiP↑, 1,   AntiViral↑, 7,   Bacteria↓, 18,   Diar↓, 3,   GutMicro↑, 21,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↑, 3,   Ingr↝, 9,  
Total Targets: 444

Scientific Paper Hit Count for: Synergy, Synergy
23 Curcumin
16 Vitamin C (Ascorbic Acid)
15 Sulforaphane (mainly Broccoli)
15 Melatonin
14 Quercetin
13 Metformin
13 Chrysin
12 Dichloroacetate
11 Lycopene
10 Silver-NanoParticles
10 Chemotherapy
10 EGCG (Epigallocatechin Gallate)
9 Resveratrol
9 immunotherapy
9 mebendazole
8 Artemisinin
8 Ashwagandha(Withaferin A)
8 Fisetin
7 Atorvastatin
7 Berberine
7 Phenethyl isothiocyanate
6 Radiotherapy/Radiation
6 Hyperthermia
6 Magnetic Fields
6 Apigenin (mainly Parsley)
6 Vitamin K2
6 Silymarin (Milk Thistle) silibinin
6 phytic acid, Inositol hexakisphosphate
6 Inositol
6 Bicarbonate(Sodium)
6 Thymoquinone
5 3-bromopyruvate
5 Photodynamic Therapy
5 Dipyridamole
5 Carvacrol
5 diet FMD Fasting Mimicking Diet
5 Fenbendazole
5 Formononetin
5 Flaxseed/Linseed
5 Gambogic Acid
5 Matrine
5 Phycocyanin
5 Rosmarinic acid
5 VitK3,menadione
4 Auranofin
4 Alpha-Lipoic-Acid
4 Gemcitabine (Gemzar)
4 Isothiocyanates
4 Propolis -bee glue
4 Capsaicin
4 salinomycin
4 diet Methionine-Restricted Diet
4 Dandelion Root
4 Disulfiram
4 doxorubicin
4 Hydrogen Gas
4 MCT, metronomic chemo
4 Piperlongumine
4 Urolithin
3 1,8-Cineole
3 Astaxanthin
3 beta-carotene(VitA)
3 Benzyl isothiocyanate
3 borneol
3 Caffeic acid
3 Carnosic acid
3 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
3 chaetocin
3 chitosan
3 5-fluorouracil
3 Copper and Cu NanoParticles
3 Piperine
3 Chlorella (Chlorella vulgaris)
3 Spirulina(Arthrospira/Limnospira)
3 Diindolylmethane
3 Mistletoe/Viscum album Extracts
3 Emodin
3 Eugenol
3 Genistein (soy isoflavone)
3 Honokiol
3 Ivermectin
3 Juglone
3 Kaempferol
3 Luteolin
3 methylseleninic acid
3 Terpinen-4-ol / Tea Tree Oil
3 Selenium NanoParticles
3 Zyflamend
2 2-DeoxyGlucose
2 cetuximab
2 Vitamin B12
2 Folic Acid, Vit B9
2 chemodynamic therapy
2 SonoDynamic Therapy UltraSound
2 Trichostatin A
2 Allicin (mainly Garlic)
2 Andrographis
2 isoquercitrin
2 Aspirin
2 Baicalein
2 Biochanin A
2 Betulinic acid
2 Lutein
2 Zeaxanthin
2 Allyl isothiocyanate
2 hydroxychloroquine
2 Thymol-Thymus vulgaris
2 Sorafenib (brand name Nexavar)
2 Camu camu
2 Chlorogenic acid
2 Trastuzumab
2 Citric Acid
2 Coenzyme Q10
2 Ellagic acid
2 Bortezomib
2 Docosahexaenoic Acid
2 Oxygen, Hyperbaric
2 Indole-3-carbinol
2 Vitamin A, Retinoic Acid
2 erastin
2 Exercise
2 Ferulic acid
2 ferumoxytol
2 Fucoidan
2 Gallic acid
2 Cisplatin
2 Gamma-aminobutyric acid
2 Ginkgetin
2 Gossypol/AT-101
2 HydroxyCitric Acid
2 Spermidine
2 L-Theanine
2 Lecithin
2 Mung Bean Sprouts
2 Methyl Jasmonate
2 Magnetic Field Rotating
2 magnetic nanoparticles
2 Lemon Balm/Melissa officinalis
2 Morin
2 Methylsulfonylmethane
2 Niclosamide (Niclocide)
2 Phenylbutyrate
2 Shikonin
2 Selenite (Sodium)
2 Vitamin D3
1 Serotonin, 5-hydroxytryptamine
1 dietMediterranean
1 EMF
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Anti-oxidants
1 Acer okamotoanum
1 5-Aminolevulinic acid
1 almonertinib
1 D-limonene
1 Huperzine A/Huperzia serrata
1 Bufalin/Huachansu
1 Bifidobacterium
1 Boron
1 Boswellia (frankincense)
1 Butyrate
1 Cannabidiol
1 Centella asiatica / Gotu kola → asiaticoside
1 Beta‐Lapachone
1 Chlorophyllin
1 Rutin
1 Cinnamon
1 Hydroxycinnamic-acid
1 Selenium
1 Cucurbitacin
1 Vitamin B1/Thiamine
1 Dasatinib/Phyrago
1 Diclofenac
1 diet Ketogenic
1 Ormeloxifene (Centchroman)
1 Docetaxel
1 Ascorbyl Palmitate
1 Echinacea
1 Electrical Pulses
1 Beta-Caryophyllene
1 temozolomide
1 Geldanamycin
1 Radicicol/monorden
1 carboplatin
1 Flaxseed Oil
1 Arsenic trioxide
1 olaparib/LYNPARZA
1 Galloflavin
1 verapamil
1 Garcinol
1 Ginkgo biloba
1 Germanium Organic/Ge-132 / propagermanium (organogermanium)
1 Ginkgolide B
1 Gold NanoParticles
1 Calorie Restriction Mimetics
1 iodine
1 Inulin Prebiotic
1 Isorhamnetin
1 capecitabine
1 isoorientin
1 itraconazole
1 Recombinant Methioninase
1 tumor necrosis factor-related apoptosis-inducing ligand
1 lambertianic acid
1 Lapatinib
1 low dose naltrexone
1 Licorice
1 Linalool
1 Vitamin E
1 Methylene blue
1 Magnolol
1 Bevacizumab (brand Avastin)
1 gefitinib, erlotinib
1 Dordaviprone; Modeyso
1 Sulindac
1 Modified Citrus Pectin
1 irinotecan
1 MCT oil
1 methotrexate
1 Magnesium
1 Moringa oleifera
1 Zeolite
1 Mushroom Lion’s Mane, Hericium erinaceus
1 Bacopa monnieri
1 Naringin
1 Marjoram (Origanum majorana)
1 Paclitaxel/Taxol
1 topotecan
1 Propranolol
1 Phosphatidylserine
1 Psoralidin
1 Parthenolide
1 Pterostilbene
1 Sulfasalazine
1 Sesamin
1 acetaminophen
1 acetazolamide
1 statins
1 triptolide
1 Turmerones
1 Vitexin
1 Walnut
1 Zinc
1 Bicalutamide
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1849  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page